Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 7,754 $ 24,494
Short-term investments 3,151 6,621
Accounts receivable, net 11,653 9,583
Inventories 62,799 60,816
Contract assets 9,906 7,510
Prepaid expenses and other current assets 3,082 4,000
Total current assets 98,345 113,024
Property and equipment, net 15,253 16,326
Equipment on lease, net 5,482 6,667
Other assets 17,068 17,782
Total assets 136,148 153,799
Current liabilities:    
Accounts payable 15,595 15,854
Accrued expenses and other current liabilities 6,244 6,491
Debt – current portion 34,300 21,191
Contract liabilities 4,719 5,135
Total current liabilities 60,858 48,671
Long-term debt – less current portion 2,003 11,941
Contingent earnout liabilities 1,893 1,456
Warrant liabilities 14,455 11,835
Other noncurrent liabilities 11,489 11,556
Total liabilities 90,698 85,459
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Common stock, $0.00001 par value - 500,000,000 shares authorized at March 31, 2024 and December 31, 2023, 261,704,589 and 258,418,695 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 2 2
Additional paid-in capital 430,843 425,471
Accumulated other comprehensive loss (44) (96)
Accumulated deficit (385,351) (357,037)
Total stockholders’ equity 45,450 68,340
Total liabilities and stockholders’ equity $ 136,148 $ 153,799